{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:57:58Z","timestamp":1793073478949,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007259","name":"Institut Ru\u0111er Bo\u0161kovi\u0107","doi-asserted-by":"publisher","award":["202301564B0"],"award-info":[{"award-number":["202301564B0"]}],"id":[{"id":"10.13039\/501100007259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.hbpd.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T17:44:39Z","timestamp":1729619079000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sequential living donor liver transplantation after liver resection optimizes outcomes for patients with high-risk hepatocellular carcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Itsuko Chih-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona Bettina P","family":"Dungca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Chien","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2024.10.003_bib0001","doi-asserted-by":"crossref","unstructured":"Sposito C, Mazzaferro V. Liver transplantation for hepatocellular carcinoma. In: Ettorre GM, ed. Hepatocellular carcinoma. updates in surgery. Cham: Springer; 2021.","DOI":"10.1007\/978-3-031-09371-5_19"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0002","article-title":"New frontiers in liver resection for hepatocellular carcinoma","volume":"2","author":"Allaire","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0003","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejim.2014.03.001","article-title":"Multimodal treatment of hepatocellular carcinoma","volume":"25","author":"Graf","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0004","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0006","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0007","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.28339","article-title":"Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection","volume":"63","author":"Ferrer-F\u00e0brega","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0008","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11605-015-3018-6","article-title":"When should we propose liver transplant after resection of hepatocellular carcinoma? A comparison of salvage and de principe strategies","volume":"20","author":"Tribillon","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.24680","article-title":"Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis","volume":"55","author":"Fuks","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.21431","article-title":"Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation","volume":"14","author":"Scatton","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0011","doi-asserted-by":"crossref","first-page":"602","DOI":"10.12659\/AOT.905779","article-title":"Liver transplantation for high risk hepatocellular carcinoma after liver resection: a sequential or salvage approach?","volume":"22","author":"Lin","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0012","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/SLA.0000000000002889","article-title":"Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma","volume":"268","author":"Pinna","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0013","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0014","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jso.21461","article-title":"Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis","volume":"101","author":"Schiffman","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0016","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/lt.20202","article-title":"High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation","volume":"10","author":"Sala","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0017","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/TP.0b013e3181622ff8","article-title":"Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan","volume":"85","author":"Concejero","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0018","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1097\/00007890-200006270-00018","article-title":"Minimal blood loss living donor hepatectomy","volume":"69","author":"Chen","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0019","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/he.2000.5763","article-title":"Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis","volume":"31","author":"Majno","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/lt.24758","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis","volume":"23","author":"Menahem","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1477-2574.2009.00073.x","article-title":"Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria","volume":"11","author":"Facciuto","year":"2009","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0023","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archsurg.139.3.320","article-title":"Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver","volume":"139","author":"Chang","year":"2004","journal-title":"Arch Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000658-199603000-00011","article-title":"Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series","volume":"223","author":"Fuster","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0026","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17474124.2020.1791704","article-title":"A 2020 update on liver transplant for hepatocellular carcinoma","volume":"14","author":"Finotti","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","article-title":"Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation","volume":"235","author":"Poon","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0029","doi-asserted-by":"crossref","first-page":"e48932","DOI":"10.1371\/journal.pone.0048932","article-title":"Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archsurg.2007.15","article-title":"Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant","volume":"143","author":"Ng","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0031","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.transproceed.2007.05.073","article-title":"First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis","volume":"39","author":"Vennarecci","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0032","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","article-title":"A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients","volume":"220","author":"Agopian","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0033","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.sla.0000090449.87109.44","article-title":"Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?","volume":"238","author":"Adam","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SLA.0000000000001442","article-title":"Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes?","volume":"264","author":"Bhangui","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijsu.2018.04.041","article-title":"The surgical challenges of salvage living donor liver transplantation for hepatocellular carcinoma; the cumulative experience of 100 cases - a retrospective cohort study and a propensity score analysis","volume":"54","author":"Yong","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0036","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.sla.0000098621.74851.65","article-title":"Resection prior to liver transplantation for hepatocellular carcinoma","volume":"238","author":"Belghiti","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0037","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.transproceed.2014.07.031","article-title":"Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection","volume":"46","author":"Tuci","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.3112","article-title":"Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant","volume":"156","author":"Lai","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0039","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/lt.23902","article-title":"Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation","volume":"20","author":"Samoylova","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0040","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.27272","article-title":"Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment","volume":"60","author":"Halazun","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0041","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nrgastro.2013.194","article-title":"Why does living donor liver transplantation flourish in Asia?","volume":"10","author":"Chen","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0042","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/lt.23521","article-title":"Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0043","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.4254\/wjh.v8.i31.1309","article-title":"Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma","volume":"8","author":"Yang","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0044","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/lt.23904","article-title":"Alpha-fetoprotein level >1000 ng\/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria","volume":"20","author":"Hameed","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0046","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.3390\/cancers15205030","article-title":"Primary versus salvage liver transplantation after curative-intent resection or radiofrequency ablation for hepatocellular carcinoma: long-term oncological outcomes","volume":"15","author":"Anselmo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0047","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00268-019-05051-6","article-title":"Preoperative predictors including the role of inflammatory indices in predicting early recurrence after re-resection for recurrent hepatocellular carcinoma","volume":"43","author":"Guo","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0048","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/lt.23605","article-title":"Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?","volume":"19","author":"Chan","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0049","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-6143.2009.02750.x","article-title":"Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor","volume":"10","author":"Vibert","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0050","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.3389\/ti.2022.10412","article-title":"Progression of AFP SCORE is a preoperative predictive factor of microvascular invasion in selected patients meeting liver transplantation criteria for hepatocellular carcinoma","volume":"35","author":"Herrero","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0051","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.3748\/wjg.v20.i45.17132","article-title":"Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0052","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jhbp.412","article-title":"Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study","volume":"24","author":"Takada","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0053","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21037\/hbsn-21-379","article-title":"Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation","volume":"11","author":"Chen","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0054","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijsu.2019.07.035","article-title":"FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study","volume":"69","author":"Ling","year":"2019","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/TP.0000000000001297","article-title":"Combination of FDG-PET and UCSF criteria for predicting HCC recurrence after living donor liver transplantation","volume":"100","author":"Hsu","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0056","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","article-title":"Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within Milan criteria: a multicenter study","volume":"16","author":"Mehta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0057","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0058","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications","volume":"243","author":"Portolani","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0059","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/hpb.12367","article-title":"Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection","volume":"17","author":"Cheng","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0061","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0062","series-title":"Hepatocellular carcinoma. updates in surgery","article-title":"Hepatocellular carcinoma recurrence: how to manage","author":"Pagano","year":"2013"},{"key":"10.1016\/j.hbpd.2024.10.003_bib0063","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11605-020-04553-2","article-title":"Early versus late recurrence of hepatocellular carcinoma after surgical resection based on post-recurrence survival: an international multi-institutional analysis","volume":"25","author":"Wei","year":"2021","journal-title":"J Gastrointest Surg"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387224001279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387224001279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T22:57:57Z","timestamp":1740610677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387224001279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1499387224001279"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2024.10.003","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential living donor liver transplantation after liver resection optimizes outcomes for patients with high-risk hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}